New technologies are bringing into effect rapid change across the pharma industry, but no other aspect of the business is seeing innovation at the scale and speed of the clinical trial spac
In the latest episode of the pharmaphorum podcast, Dr Paul Tunnah speaks to head of Patient Engagement at Syneos Health, Marie Emms, and Elligo Health Research vice president, strategic partnership
The pharma industry has been talking about being patient-centric for years, but often that rhetoric hasn’t been accompanied by real change in the way product development is carried out.
Back in January, pharmaphorum caught up with the Syneos Health team to discuss their experience and insights into the emerging category of digital therapeutics (DTx), and the use of softwar
Sage Therapeutics has suffered another disappointment after deciding that it will have to drop the Parkinson’s programme for key pipeline drug dalzanemdor after it showed
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.